Efficacy, effectiveness and side effects of medications used to prevent fractures.

Reid, I R

Reid, I R.

Affiliation

Reid IR; University of Auckland, Auckland, New Zealand.

J Intern Med ; 277(6): 690-706, 2015 Jun.

Article in En | MEDLINE | ID: mdl-25495429

Subject(s)

Bone Density Conservation Agents/administration & dosage; Diphosphonates/administration & dosage; Hip Fractures/prevention & control; Osteoporotic Fractures/prevention & control; Spinal Fractures/prevention & control; Alendronate/administration & dosage; Antibodies, Monoclonal, Humanized/administration & dosage; Bone Density Conservation Agents/adverse effects; Calcium Compounds/administration & dosage; Denosumab; Diphosphonates/adverse effects; Etidronic Acid/administration & dosage; Etidronic Acid/analogs & derivatives; Evidence-Based Medicine; Humans; Ibandronic Acid; Imidazoles/administration & dosage; Osteoporosis/prevention & control; Raloxifene Hydrochloride/administration & dosage; Risedronic Acid; Risk Assessment; Teriparatide/administration & dosage; Thiophenes/administration & dosage; Treatment Outcome; Vitamin D/administration & dosage; Zoledronic Acid

Key words

SERM; bisphosphonate; calcium; denosumab; osteoporosis; strontium; vitamin D

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Spinal Fractures / Diphosphonates / Bone Density Conservation Agents / Osteoporotic Fractures / Hip Fractures Type of study: Etiology_studies Language: En Journal: J Intern Med Year: 2015 Type: Article Affiliation country: New Zealand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google